sennosides, USP Oral Tablet

RxNorm concept 373859, clinical dose form (scdf).

RxCUI: 373859
Term type: Clinical dose form (SCDF)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/373859 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

sennosides, USP 36387

Related concepts

Oral Tablet (DF, has dose form)
sennosides, USP (IN, has ingredient)
sennosides, USP Oral Tablet [Ex-Lax Maximum Relief Formula] (SBDF, has tradename)
sennosides, USP Oral Tablet [Ex-Lax Regular Strength Pills] (SBDF, has tradename)
sennosides, USP Oral Tablet [Perdiem Overnight] (SBDF, has tradename)
sennosides, USP Oral Tablet [SenoSol] (SBDF, has tradename)
sennosides, USP Oral Tablet [Senokot] (SBDF, has tradename)
sennosides, USP Oral Tablet [Senna-Time] (SBDF, has tradename)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 373859 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/373859 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 373859. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.